These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 26892177)

  • 1. Downregulation of cytokeratin 18 is associated with paclitaxel‑resistance and tumor aggressiveness in prostate cancer.
    Yin B; Zhang M; Zeng Y; Li Y; Zhang C; Getzenberg RH; Song Y
    Int J Oncol; 2016 Apr; 48(4):1730-6. PubMed ID: 26892177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Down-regulation of E-cadherin enhances prostate cancer chemoresistance via Notch signaling.
    Wang W; Wang L; Mizokami A; Shi J; Zou C; Dai J; Keller ET; Lu Y; Zhang J
    Chin J Cancer; 2017 Mar; 36(1):35. PubMed ID: 28356132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The establishment of two paclitaxel-resistant prostate cancer cell lines and the mechanisms of paclitaxel resistance with two cell lines.
    Takeda M; Mizokami A; Mamiya K; Li YQ; Zhang J; Keller ET; Namiki M
    Prostate; 2007 Jun; 67(9):955-67. PubMed ID: 17440963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Knockdown of lncRNA CCAT1 enhances sensitivity of paclitaxel in prostate cancer via regulating miR-24-3p and FSCN1.
    Li X; Han X; Wei P; Yang J; Sun J
    Cancer Biol Ther; 2020 May; 21(5):452-462. PubMed ID: 32089062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Skp2 is associated with paclitaxel resistance in prostate cancer cells.
    Yang Y; Lu Y; Wang L; Mizokami A; Keller ET; Zhang J; Fu J
    Oncol Rep; 2016 Jul; 36(1):559-66. PubMed ID: 27175797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acquisition of paclitaxel resistance is associated with a more aggressive and invasive phenotype in prostate cancer.
    Kim JJ; Yin B; Christudass CS; Terada N; Rajagopalan K; Fabry B; Lee DY; Shiraishi T; Getzenberg RH; Veltri RW; An SS; Mooney SM
    J Cell Biochem; 2013 Jun; 114(6):1286-93. PubMed ID: 23192682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CTEN/tensin 4 expression induces sensitivity to paclitaxel in prostate cancer.
    Li Y; Mizokami A; Izumi K; Narimoto K; Shima T; Zhang J; Dai J; Keller ET; Namiki M
    Prostate; 2010 Jan; 70(1):48-60. PubMed ID: 19725034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Upregulation of PI3K/Akt and MAP Kinase Pathways is Associated with Resistance of Microtubule-Targeting Drugs in Prostate Cancer.
    Liu Z; Zhu G; Getzenberg RH; Veltri RW
    J Cell Biochem; 2015 Jul; 116(7):1341-9. PubMed ID: 25640606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CCL2 induces resistance to the antiproliferative effect of cabazitaxel in prostate cancer cells.
    Natsagdorj A; Izumi K; Hiratsuka K; Machioka K; Iwamoto H; Naito R; Makino T; Kadomoto S; Shigehara K; Kadono Y; Lin WJ; Maolake A; Mizokami A
    Cancer Sci; 2019 Jan; 110(1):279-288. PubMed ID: 30426599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Downregulation of cytokeratin 18 enhances BCRP-mediated multidrug resistance through induction of epithelial-mesenchymal transition and predicts poor prognosis in breast cancer.
    Shi R; Wang C; Fu N; Liu L; Zhu D; Wei Z; Zhang H; Xing J; Wang Y
    Oncol Rep; 2019 May; 41(5):3015-3026. PubMed ID: 30896886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The CCL2-CCR2 Axis Contributes to Migration of Cabazitaxel-resistant Prostate Cancer Cells.
    Natsagdorj A; Izumi K; Hiratsuka K; Naito R; Kadomoto S; Iwamoto H; Yaegashi H; Shigehara K; Nakata H; Mizokami A
    Anticancer Res; 2023 Jun; 43(6):2561-2569. PubMed ID: 37247914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Micellar Delivery of miR-34a Modulator Rubone and Paclitaxel in Resistant Prostate Cancer.
    Wen D; Peng Y; Lin F; Singh RK; Mahato RI
    Cancer Res; 2017 Jun; 77(12):3244-3254. PubMed ID: 28428276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of the SHH gene in prostate cancer cell resistance to paclitaxel.
    Statkiewicz M; Maryan N; Lipiec A; Grecka E; Grygorowicz MA; Omiotek M; Gorska A; Mikula M; Malecki M
    Prostate; 2014 Aug; 74(11):1142-52. PubMed ID: 24925370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytokeratin 18 knockdown decreases cell migration and increases chemosensitivity in non-small cell lung cancer.
    Zhang B; Wang J; Liu W; Yin Y; Qian D; Zhang H; Shi B; Li C; Zhu J; Zhang L; Gao L; Wang C
    J Cancer Res Clin Oncol; 2016 Dec; 142(12):2479-2487. PubMed ID: 27601168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo establishment and characterization of a paclitaxel-resistant human ovarian cancer cell line showing enhanced growth properties and drug-resistance only in vivo.
    Okugawa K; Kobayashi H; Hirakawa T; Sonoda T; Ogura T; Nakano H
    J Cancer Res Clin Oncol; 2004 Mar; 130(3):178-86. PubMed ID: 14655049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Synergic effects of the combination of VEGF-targeted shRNA and taxol on human prostate cancer DU145 both in vitro and in vivo].
    Li BW; Zhang M; He HW; Zhang SH; Shao RG
    Yao Xue Xue Bao; 2009 Mar; 44(3):296-302. PubMed ID: 19449527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of PER3 reverses paclitaxel resistance of prostate cancer cells by inhibiting the Notch pathway.
    Cai DW; Chen D; Sun SP; Liu ZJ; Liu F; Xian SZ; Wu PS; Kong GQ
    Eur Rev Med Pharmacol Sci; 2018 May; 22(9):2572-2579. PubMed ID: 29771413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acquisition of chemoresistant phenotype by overexpression of the antiapoptotic gene testosterone-repressed prostate message-2 in prostate cancer xenograft models.
    Miyake H; Nelson C; Rennie PS; Gleave ME
    Cancer Res; 2000 May; 60(9):2547-54. PubMed ID: 10811138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ETS1 promotes chemoresistance and invasion of paclitaxel-resistant, hormone-refractory PC3 prostate cancer cells by up-regulating MDR1 and MMP9 expression.
    Kato T; Fujita Y; Nakane K; Kojima T; Nozawa Y; Deguchi T; Ito M
    Biochem Biophys Res Commun; 2012 Jan; 417(3):966-71. PubMed ID: 22206665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differentially expressed proteins in human breast cancer cells sensitive and resistant to paclitaxel.
    Pavlikova N; Bartonova I; Dincakova L; Halada P; Kovar J
    Int J Oncol; 2014 Aug; 45(2):822-30. PubMed ID: 24898082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.